Sign in Subscribe
Cancer

Tailoring Interpersonal Psychotherapy to Psycho-Oncology Patients Shows Promise in Reducing Depression and Anxiety Symptoms

Strategic Insights

— 2 min read

Patients with cancer suffering from comorbid symptoms of depression can benefit from a psychotherapeutic treatment specifically tailored to the exceptional context of acute or chronic cancer treatment, according to new research. The study, conducted by the University Hospital Tubingen in Tubingen, Germany, found that a modified group interpersonal psychotherapy (IPT) intervention can be an acceptable, feasible, and safe approach to ameliorate symptoms of depression in patients with cancer. The intervention focuses on coping with stressful life events, managing change, and accessing social support, and has shown promising results in reducing symptoms of depression and anxiety.

Key Takeaways:

  • The study found that a modified group IPT intervention can be adapted to the oncology setting and is feasible and acceptable for adult patients with cancer.
  • The intervention comprises 10 weekly sessions of 60 minutes each, structured into modules incorporating IPT core themes: role transitions, grief, connection, and interpersonal conflict.
  • The study aims to ascertain the feasibility and acceptability of the intervention, as well as its efficacy in reducing symptoms of depression and anxiety, and changes in interpersonal factors such as loneliness and perceived social support.
  • The research suggests that investigating group IPT as proposed is a new and innovative approach to treating patients with cancer, creating a setting that is naturalistic and realistic in the context of psycho-oncology services.
  • The study was conducted in collaboration with Dr. Rita Acebo de Arriba and her team at the University Hospital Tubingen, and is published in the journal Frontiers in Psychiatry.
  • The study's findings have implications for the development of psycho-oncology services and the treatment of patients with cancer.

Statistics:

  • The intervention consists of 10 weekly sessions of 60 minutes each.
  • The study aims to assess the feasibility and acceptability of the intervention in 100 patients.
  • The study will collect data on symptoms of depression and anxiety, changes in interpersonal factors, and post-intervention semi-structured interviews.
  • The study's sample size is limited to 100 patients, and it is unclear whether the results can be generalized to a larger population.
  • The study was conducted in a university clinics' outpatient treatment setting.

Sources:

  • Tailoring interpersonal psychotherapy to psycho-oncology patients (TIPTOP): feasibility study protocol. Frontiers in Psychiatry, 2025;16:1531756.
  • Frontiers in Psychiatry can be contacted at: Frontiers Media Sa, Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland.
  • NewsRx. University Hospital Tubingen Reports Findings in Cancer [Tailoring interpersonal psychotherapy to psycho-oncology patients (TIPTOP): feasibility study protocol]. Psychology & Psychiatry Journal. May 31, 2025; p 484.

Read more